Volume spike MVEE.F iShares Edge MSCI Europe Min Vol ESG (Acc) XETRA 04 Feb 2026: 750x volume
MVEE.F stock spikes 750x volume on XETRA 04 Feb 2026; price €6.66 and Meyka AI forecast included
-
-
NVO Stock Today, February 04: Shares Plunge on 2026 Sales Cut
Novo Nordisk stock plunges as 2026 revenue guidance is cut 5–13% amid U.S. price pressure, Wegovy price cuts, and Ozempic competition. What German investors should watch now.
-
Down 50%: Greenrise Global Brands (XCX.CN CNQ) Feb 04 market hours: liquidity risk
XCX.CN stock falls 50% to CAD 0.005 on Feb 04 2026 market hours; analysis of liquidity, valuation and Meyka AI forecast
-
TKM.AX Trek Metals up 33% pre-market 05 Feb 2026: catalysts to watch
TKM.AX stock jumps 33% pre-market on ASX; we analyse drivers, metrics and Meyka AI forecasts
-
Jill Biden Trend February 5: Ex-Husband Murder Charge Spurs Policy Risk
Jill Biden trend on 5 Feb after ex-husband William Stevenson faces first-degree murder charge in a Delaware domestic dispute. What this means for ASX headline risk.
-
Rebound: NRGOF Newrange Gold (PNK) at USD 0.0473 04 Feb 2026: oversold bounce
NRGOF stock rebounds to USD 0.0473 04 Feb 2026. Short-term bounce targets and Meyka AI forecast for NRGOF stock
-
CAMLINFINE.NS up 19.99% pre-market to INR 168.85: watch volume and earnings catalyst
CAMLINFINE.NS stock jumps 19.99% pre-market to INR 168.85 with heavy volume; outlook and Meyka AI forecast included
-
MLFXO.PA stock jumps 12.63% to €4.28 at EURONEXT close 04 Feb 2026: Monitor volume
MLFXO.PA stock up 12.63% to €4.28 on EURONEXT close 04 Feb 2026. High-volume mover analysis and price targets.
-
WhiteBIT Coin USD Breaks Below $50 as -4.30% Decline Tests Support
WBTUSD drops 4.30% to $49.20. Technical analysis reveals RSI at 57.5 and support at $53.86. Market data and forecast insights.
-
Japan Influenza B Surge February 05: School Closures Risk Demand
Influenza B outbreak Japan intensifies, with Sendai at 37.88 cases per facility and Toyama at advisory levels. We assess school closures risk, demand shifts for medicines, and near-term impacts on JP,
